XTuit Pharmaceuticals, Inc. is a biopharmaceutical company developing novel microenvironment-activated therapeutics targeting key mechanisms resulting in hypoxia, decreased drug uptake, drug resistance, and decreased immune response.

from http://xtuit.com/

Patents show all

12Applications1Issued

SEC Filings show all

D3

SEC Form D Funding Events

DateOfferedSoldType
2014-12-05$10,000,000$4,000,000Equity
2014-01-31$1,508,513$1,508,513Equity

Key Executives

  • Alan Crane
    Executive Officer, Director
  • Rakesh Jain
    Director
  • Robert Langer
    Director